New Research: Antithrombotic use shown to improve COVID-19
15 March 2022
Research from the BHF Data Science Centre’s CVD-COVID-UK Consortium suggests the use of blood-thinning medications in patients with cardiovascular disease is associated with lower risk of death from COVID-19.
 published today from the ’s CVD-COVID-UK Consortium suggests the use of blood-thinning medications in patients with cardiovascular disease is associated with lower risk of death from COVID-19.Â
IHI’s Alex Handy, the lead researcher of the study, said “We observed that people already taking antithrombotics were marginally less likely to die from COVID-19, but were also marginally more likely to be hospitalised. We saw the same pattern in people taking other blood thinning drugs called anticoagulants.Â
“This pattern could be a result of people taking this kind of medication being more likely to access healthcare, but it may also mean that antithrombotics only help in the most serious cases of COVID-19. Â
Credits to HDR UK Comms Team.